Therapeutic Product Stocks List

Recent Signals

Date Stock Signal Type
2021-02-26 ANIK Fell Below 20 DMA Bearish
2021-02-26 ANIK Fell Below 200 DMA Bearish
2021-02-26 BPTH 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-26 BPTH Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-26 BPTH Narrow Range Bar Range Contraction
2021-02-26 BPTH Fell Below 20 DMA Bearish
2021-02-26 BPTH NR7 Range Contraction
2021-02-26 CGEN Calm After Storm Range Contraction
2021-02-26 CGEN Lower Bollinger Band Walk Weakness
2021-02-26 CL Lower Bollinger Band Walk Weakness
2021-02-26 CRMD MACD Bearish Signal Line Cross Bearish
2021-02-26 IMMP Doji - Bullish? Reversal
2021-02-26 IMMP Stochastic Buy Signal Bullish
2021-02-26 IRWD Pocket Pivot Bullish Swing Setup
2021-02-26 IRWD Lower Bollinger Band Walk Weakness
2021-02-26 KROS Doji - Bullish? Reversal
2021-02-26 KROS 20 DMA Support Bullish
2021-02-26 KROS Hammer Candlestick Bullish
2021-02-26 MMSI MACD Bearish Centerline Cross Bearish
2021-02-26 MMSI Pocket Pivot Bullish Swing Setup
2021-02-26 MMSI Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-02-26 MTP Fell Below 50 DMA Bearish
2021-02-26 MTP 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-26 NYMX New Downtrend Bearish
2021-02-26 NYMX Stochastic Reached Oversold Weakness
2021-02-26 NYMX 200 DMA Resistance Bearish
2021-02-26 NYMX Fell Below 50 DMA Bearish
2021-02-26 SRNE MACD Bearish Centerline Cross Bearish
2021-02-26 STSA Fell Below 50 DMA Bearish
2021-02-26 THMO 50 DMA Support Bullish
2021-02-26 THMO New Downtrend Bearish
2021-02-26 VIR 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-26 VIR Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-26 YMAB Lower Bollinger Band Walk Weakness
2021-02-26 YMAB New Downtrend Bearish

Recent News for Therapeutic Product Stocks

Date Stock Title
Feb 27 SRNE SORRENTO INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sorrento Therapeutics, Inc. - SRNE
Feb 26 CGEN Compugen Ltd. (CGEN) Q4 2020 Earnings Call Transcript
Feb 26 MNKD MannKind Corporation 2020 Q4 - Results - Earnings Call Presentation
Feb 26 YMAB Y-mAbs Therapeutics' (YMAB) CEO Claus Moller on Q4 2020 Results - Earnings Call Transcript
Feb 26 ALXN SHAREHOLDER ALERT: WeissLaw LLP Reminds BFTL, ALXN, STPK, and BRPA Shareholders About Its Ongoing Investigations
Feb 26 AMGN AstraZeneca/Amgen's Tezepelumab Reduces Asthma Exacerbations, Phase 3 Trial Shows
Feb 26 AMGN AstraZeneca and Amgen's tezepelumab successful in phase 3 for severe asthma
Feb 26 MNKD What Does MannKind's Debt Look Like?
Feb 26 AMRN Amarin (AMRN) Q4 Earnings & Revenues Top, Vascepa Sales Solid
Feb 26 YMAB Y-mAbs Therapeutics, Inc. 2020 Q4 - Results - Earnings Call Presentation
Feb 26 AMGN AstraZeneca-Amgen drug could widen treatment options for severe asthma
Feb 26 HRC Allscripts (MDRX) Q4 Earnings and Revenues Beat Estimates
Feb 26 AMGN Tezepelumab Is The First Biologic To Significantly Reduce Exacerbations In Broad Population Of Patients With Severe, Uncontrolled Asthma
Feb 26 YMAB Y-mAbs Therapeutics, Inc. to Host Earnings Call
Feb 26 MMSI Should You Be Impressed By Merit Medical Systems' (NASDAQ:MMSI) Returns on Capital?
Feb 26 MNKD MannKind Corporation (MNKD) Q4 2020 Earnings Call Transcript
Feb 25 CGEN Compugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q4 2020 Results - Earnings Call Transcript
Feb 25 YMAB Y-mAbs Therapeutics EPS beats by $0.19, beats on revenue
Feb 25 VIR Vir Biotechnology EPS misses by $0.11, misses on revenue
Feb 25 HRC Hillrom to Present at the Barclays Global Healthcare Conference